Significant fluorescence enhancement by supramolecular complex formation between berberine chloride and cucurbit( n = 7)uril and its analytical application
The supramolecular interaction of cucurbit( n = 7)uril (Q[7]) with berberine chloride (BER) has been studied in aqueous solution at pH 2.0 and room temperature by spectro-fluorimetry. The association constant of the complex was 2.07 × 10 6 L mol −1 calculated by using a nonlinear least squares metho...
Saved in:
Published in | Talanta (Oxford) Vol. 84; no. 3; pp. 684 - 689 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
15.05.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The supramolecular interaction of cucurbit(
n
=
7)uril (Q[7]) with berberine chloride (BER) has been studied in aqueous solution at pH 2.0 and room temperature by spectro-fluorimetry. The association constant of the complex was 2.07
×
10
6
L
mol
−1 calculated by using a nonlinear least squares method.
1H NMR spectra confirmed that a 1:1 stable complex is formed between Q[7] and BER. This work proposes a possible interaction mode, in which the guest BER is incorporated inside the hydrophobic cavity of the host Q[7] via the isoquinoline ring part of the guest molecule. Based on a significant enhancement of the fluorescence intensity of this supramolecular complex, a spectrofluorimetric method with high sensitivity and selectivity has been developed for the determination of BER in aqueous solution in the presence of Q[7]. The linear range of the method was from 7.43 to 11.2
×
10
3
ng
mL
−1with the detection limit 4.2
ng
mL
−1. There was no interference from the compounds normally used in tablets, serum or urine constituents. The proposed method was applied to the determination of BER in tablets, serum and urine samples with satisfactory results and good consistency with those obtained by the pharmacopoeia method. This shows that it has promising potential for therapeutic drug monitoring and pharmokinetics and for clinical application. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0039-9140 1873-3573 |
DOI: | 10.1016/j.talanta.2011.01.071 |